The effect of triamcinolone and Q10 coenzyme in the treatment of oral lichen planus

Phase 3

Recruiting

• Conditions: oral lichen planus.; Lichen planus

• Registration Number: IRCT20201127049502N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Patients with symptomatic oral lichen planus (erosive or atrophic form) who have a sense of burning or pain.
The diagnosis is clinical (Wickham striae or papules) and in cases in which a definitive diagnosis of the lesion is difficult, a histopathological evaluation will be used.
The patient should not have used topical corticosteroid treatments in the last two weeks or systemic corticosteroids in the last month.
The patient should not have used analgesics and anesthetics.

Exclusion Criteria

Patients with lichenoid lesions caused by medication or dental materials
Pregnant or lactating patients
Patients with other lesions such as leukoplakia and systemic lupus in conjunction with lichen planus
History of malignancy
Non-cooperative patients and patients who do not use drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity and size of the lesions based on REU index. Timepoint: baseline(day0), day15, day30. Method of measurement: Graded tongue blade.;Amount of healing based on E?cacy Index. Timepoint: baseline(day0), day15, day30. Method of measurement: formula.;Severity of burning sensation based on VAS Index. Timepoint: baseline(day0), day15, day30. Method of measurement: Scoring by the patient.